Introduction: Preeclampsia is one of the most commonly disorders of pregnancy. The pressor response to laryngoscopy is known to be exaggerated in patients with severe preeclampsia. The aim of this study was to assess the preoperative blood pressure control in severe preeclamptic mother with intravenous nitroglycerine is more effectively attenuate the haemodynamic response to laryngoscopy in comparison to treatment with intravenous hydralazine. Methods: This randomized fixed sealed envelope lottery method study was conducted in the Department of anaesthesiology of Dhaka Medical College Hospital, Dhaka, between October 2014 to March 2015 Total of 60 patients with severe preeclampsia and gestational age more than 36 weeks, who were presented for elective or urgent caesarean delivery under general anaesthesia were randomly divided into two groups, group A, n=30 received 50 mcg intravenous nitroglycerine. Group B received 5mg hydralazine intravenously very slowly. Heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and mean arterial pressure (MAP) were simultaneously recorded in the mother at pre-induction, pre-laryngoscopy, and at 1min, 3 min, and 5 min after laryngoscopy. Result: The patients in group A and group B showed no significant difference in HR, SAP, DAP and MAP at pre induction and pre laryngoscopy. But there is significant difference (P<0.05) at 1, 3, 5 min after laryngoscopy. The mean heart rate at 1, 3 and 5 minutes after laryngoscopy were significantly (p<0.05) higher in group B than group A. The mean SAP, DAP, MAP were also significantly (p<0.05) higher in group B than group A at 1, 3, 5 min after laryngoscopy. Conclusion: Women with severe preeclampsia who were preoperatively treated with intravenous nitroglycerine provides a safe and more effective prophylaxis for patients with severe preeclampsia undergoing cesarean delivery under general anesthesia, in attenuating haemodynamic responses to laryngoscopy.
Published in | International Journal of Anesthesia and Clinical Medicine (Volume 9, Issue 2) |
DOI | 10.11648/j.ijacm.20210902.13 |
Page(s) | 32-37 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Attenuation, Pressor, Laryngoscopy, Preeclampsia, Intravenous Nitroglycerine & Hydralazine
[1] | Am Fam Physician, 2002, Jul 15; 66 (2): 330-331. |
[2] | Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137. |
[3] | Khan KS, Wojdyla D, Say L, Gulmenzoglu AM, Van Look PF. WHO analysis of causes of maternal death: a system review. Lancet 2006; 367: 1066-74. |
[4] | Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy. Hypertension in Pregnancy 2001; 20: 9-14. |
[5] | Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine. Anaesthesiology 1977; 47 (4): 381-4. |
[6] | Bruder N, Ortega D, Granthil C. Consequences and prevention methods of hemodynamic changes during larngoscopy and intatracheal intubation. Ann FrAnaesth Reanim 1992; 11 (1): 57-71. |
[7] | Hodgkinson R, Husain FJ, Hayashi RH. Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypeertension. Can Anaesth Soc J 1980; 27 (4): 389-94. |
[8] | Connell H, Dalgleish JG, Downing JW. General anaesthesia in mothers with severe pre-eclampsia/eclampsia. Br J Anaesth 1987; 59 (11): 1375-80. |
[9] | Lawes EG, Downing JW, Duncun PW, Bland B, Lavies N, Ganeg A. Fentanyl-drperidolsupplimentation of rapid sequence induction in the presence of severe pregnancy-induced and pregnancy-aggravated hypertension. Br J Anaesth 1987; 1381-91. |
[10] | Wakako M, Oda Y, Ikeda Y, Tanaka K, Hagihira S, Iwaki H et al. Effect of remifentanil on cardiovascular and bispectral index responses following the induction of anaesthesia with midazolam and subsequent tracheal intubation. J Anaesth 2010; 24 (2): 161-7. |
[11] | Magee LA, Abalose E, Von Dadelszen P, Sibai B, Easterling T, Walkinsha WS. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011; 72 (3): 394-401. |
[12] | Ashton WB, James MF, Janicki P, Uys PC. Attenuation of pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive protienuric patients undergoing caesarian section. Br J Anaesth 1991; 67 (6): 741-7. |
[13] | Ramanathan J, Sibai BM, Mabie WC, Chauhan D, Ruiz AG. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol 1988; 159 (3): 650-4. |
[14] | Longmire S, Leduc L, Jones MM, Hawkins JL, Joyce TH, 3rd, Cotton DB. The hemodynamic effects of intubation during nitroglycerin infusion in severe preeclampsia. Am J Obstet Gynecol 1991; 164 (2): 551-6. |
[15] | Trapani A, Jr, Goncalves LF, Pieres MM. Transdermal Nitroglycerin In Patient With Severe Preeclampsia With Placental Insufficiency: Effect on Doppler Velocimetry of The Uterine, Umbilical and Middle Cerebral Arteries. Ultrasound Obstet Gnecol 2011; 38 (4): 389-94. |
[16] | Kumar N, Batra YK, Bala I, Gopalan S. Nifidipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension. Can J Anaesth 1993; 40 (4): 329-33. |
[17] | Rey F, Lelorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997; 157: 1245-54. |
[18] | Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-22. |
[19] | Brown MA, Hague WM, Higgins J, Lowe S, Mccowan L, Oats J et al. The detection, investigation and management of Hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000; 40: 133-8. |
[20] | Impey L. Severe hypertension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993; 100: 959-61. |
[21] | Olsen KS, Beier-Holgersenr R. Fetal death following labatalol administration in pre-eclampsia. Acla Obstet Gynecol Scand 1992; 71: 145-7. |
[22] | Vink GJ, Moodley J, Philpott RH. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. ObstetGynecol 1980; 55: 519-22. |
[23] | Vink GJ, Moodley J. Effect of low dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 1982; 62: 475-7. |
[24] | Waisman GD, Mayorga LM, Camera MI, Vignolo CA, Martinotti A. Magnesium plus nifedipine potentiation of hypotensive effect in preeclampsia. Am J Obstet Gynecol 1988; 159: 308-9. |
[25] | Magee LA, Ornstein MP, Von Dadelzen P. Management of hypertension in pregnancy. BMJ 1999; 318: 1332-6. |
[26] | Iftikhar S, Rasheed N, Anwar M, Humayun S. Hydralazine versus glyceryl trinitrate in severe preeclampsia and eclampsia, a comparative study. JSMC 2007; 2 (2): 174-179. |
[27] | Cunningham FG, Williams JW, Leveno KJ, Bloom S, Hauth JC & Rouse DJ. 1997. Williams obstetrics. London: Prentice Hall International. |
[28] | Manna FN. Study on association of maternal serum triglyceride with preeclampsia. Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University 2008. |
[29] | Conde-Agudelo A and Belizan JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. Bjog 2000; 107: 75-83. |
[30] | Lee CJ, Hsieh TT, Chiu TH. Risk factors for pre - eclampsia in an Asian population. Int J Gynaecol Obstet 2000; 70: 327-333. |
[31] | Safavi M, Honarmand A and Azari N. Attenuation of the Pressor Response to Tracheal Intubation in Severe Preeclampsia: Relative Efficacies of Nitroglycerine Infusion, Sublingual Nifedipine, and Intravenous Hydralazine. Anesthesiology and Pain Medicine 2011; 1 (2): 81-89. |
[32] | Ramanathan J. Pathophysiology and anesthetic implications in preeclampsia. Clin Obstet Gynecol 1992; 35 (2): 414-25. |
[33] | Ring G, Krames E, Shnider SM, Wallis KL, Levinson G. Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes. Obstet Gynecol 1977; 50 (5): 598-602. |
[34] | Hill AB, Bowley CJ, Nahrwold ML, Knight PR, Kirsh MM, Denlinger JK. Intranasal administration of nitroglycerin. Anesthesiology 1981; 54 (4): 346-8. |
[35] | Mikawa K, Hasegawa M, Suzuki T, Maekawa N, Kaetsu H, Goto R, et al. Attenuation of hypertensive response to tracheal intubation with nitroglycerin. J Clin Anesth 1992; 4 (5): 367-71. |
[36] | Mahajan RP, Ramachandran R, Saxena N. Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia 1993; 48 (4): 297-300. |
[37] | Fassoulaki A, Kaniaris P. Intranasal administration of nitroglycerine attenuates the pressor responsive to laryngoscopy and intubation of the tracheal. British Journal of Anaesthesia 1983; 55 (1): 49-52. |
APA Style
Nahida Sultana, ABM Rashedul Amir, Hasina Momtaz, Md. Abu Taher. (2021). Attenuation of Pressor Response to Laryngoscopy in Severe Preeclampsia: Comparison the Efficacies Between Intravenous Nitroglycerine and Intravenous Hydralazine. International Journal of Anesthesia and Clinical Medicine, 9(2), 32-37. https://doi.org/10.11648/j.ijacm.20210902.13
ACS Style
Nahida Sultana; ABM Rashedul Amir; Hasina Momtaz; Md. Abu Taher. Attenuation of Pressor Response to Laryngoscopy in Severe Preeclampsia: Comparison the Efficacies Between Intravenous Nitroglycerine and Intravenous Hydralazine. Int. J. Anesth. Clin. Med. 2021, 9(2), 32-37. doi: 10.11648/j.ijacm.20210902.13
AMA Style
Nahida Sultana, ABM Rashedul Amir, Hasina Momtaz, Md. Abu Taher. Attenuation of Pressor Response to Laryngoscopy in Severe Preeclampsia: Comparison the Efficacies Between Intravenous Nitroglycerine and Intravenous Hydralazine. Int J Anesth Clin Med. 2021;9(2):32-37. doi: 10.11648/j.ijacm.20210902.13
@article{10.11648/j.ijacm.20210902.13, author = {Nahida Sultana and ABM Rashedul Amir and Hasina Momtaz and Md. Abu Taher}, title = {Attenuation of Pressor Response to Laryngoscopy in Severe Preeclampsia: Comparison the Efficacies Between Intravenous Nitroglycerine and Intravenous Hydralazine}, journal = {International Journal of Anesthesia and Clinical Medicine}, volume = {9}, number = {2}, pages = {32-37}, doi = {10.11648/j.ijacm.20210902.13}, url = {https://doi.org/10.11648/j.ijacm.20210902.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20210902.13}, abstract = {Introduction: Preeclampsia is one of the most commonly disorders of pregnancy. The pressor response to laryngoscopy is known to be exaggerated in patients with severe preeclampsia. The aim of this study was to assess the preoperative blood pressure control in severe preeclamptic mother with intravenous nitroglycerine is more effectively attenuate the haemodynamic response to laryngoscopy in comparison to treatment with intravenous hydralazine. Methods: This randomized fixed sealed envelope lottery method study was conducted in the Department of anaesthesiology of Dhaka Medical College Hospital, Dhaka, between October 2014 to March 2015 Total of 60 patients with severe preeclampsia and gestational age more than 36 weeks, who were presented for elective or urgent caesarean delivery under general anaesthesia were randomly divided into two groups, group A, n=30 received 50 mcg intravenous nitroglycerine. Group B received 5mg hydralazine intravenously very slowly. Heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and mean arterial pressure (MAP) were simultaneously recorded in the mother at pre-induction, pre-laryngoscopy, and at 1min, 3 min, and 5 min after laryngoscopy. Result: The patients in group A and group B showed no significant difference in HR, SAP, DAP and MAP at pre induction and pre laryngoscopy. But there is significant difference (PConclusion: Women with severe preeclampsia who were preoperatively treated with intravenous nitroglycerine provides a safe and more effective prophylaxis for patients with severe preeclampsia undergoing cesarean delivery under general anesthesia, in attenuating haemodynamic responses to laryngoscopy.}, year = {2021} }
TY - JOUR T1 - Attenuation of Pressor Response to Laryngoscopy in Severe Preeclampsia: Comparison the Efficacies Between Intravenous Nitroglycerine and Intravenous Hydralazine AU - Nahida Sultana AU - ABM Rashedul Amir AU - Hasina Momtaz AU - Md. Abu Taher Y1 - 2021/08/11 PY - 2021 N1 - https://doi.org/10.11648/j.ijacm.20210902.13 DO - 10.11648/j.ijacm.20210902.13 T2 - International Journal of Anesthesia and Clinical Medicine JF - International Journal of Anesthesia and Clinical Medicine JO - International Journal of Anesthesia and Clinical Medicine SP - 32 EP - 37 PB - Science Publishing Group SN - 2997-2698 UR - https://doi.org/10.11648/j.ijacm.20210902.13 AB - Introduction: Preeclampsia is one of the most commonly disorders of pregnancy. The pressor response to laryngoscopy is known to be exaggerated in patients with severe preeclampsia. The aim of this study was to assess the preoperative blood pressure control in severe preeclamptic mother with intravenous nitroglycerine is more effectively attenuate the haemodynamic response to laryngoscopy in comparison to treatment with intravenous hydralazine. Methods: This randomized fixed sealed envelope lottery method study was conducted in the Department of anaesthesiology of Dhaka Medical College Hospital, Dhaka, between October 2014 to March 2015 Total of 60 patients with severe preeclampsia and gestational age more than 36 weeks, who were presented for elective or urgent caesarean delivery under general anaesthesia were randomly divided into two groups, group A, n=30 received 50 mcg intravenous nitroglycerine. Group B received 5mg hydralazine intravenously very slowly. Heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and mean arterial pressure (MAP) were simultaneously recorded in the mother at pre-induction, pre-laryngoscopy, and at 1min, 3 min, and 5 min after laryngoscopy. Result: The patients in group A and group B showed no significant difference in HR, SAP, DAP and MAP at pre induction and pre laryngoscopy. But there is significant difference (PConclusion: Women with severe preeclampsia who were preoperatively treated with intravenous nitroglycerine provides a safe and more effective prophylaxis for patients with severe preeclampsia undergoing cesarean delivery under general anesthesia, in attenuating haemodynamic responses to laryngoscopy. VL - 9 IS - 2 ER -